Detection and Partial Molecular Characterization (E6–E7 Region-Early Genes) and Prevalence of Human Papillomavirus (HPV) Causing Cervical Cancer in and Around Tirupati Region, Andhra Pradesh-Reference-Cited by-同舟云学术

Detection and Partial Molecular Characterization (E6–E7 Region-Early Genes) and Prevalence of Human Papillomavirus (HPV) Causing Cervical Cancer in and Around Tirupati Region, Andhra Pradesh

Published:2023-03-09 Issue:2 Volume:21 Page:
ISSN:2363-8397
Container-title:Indian Journal of Gynecologic Oncology
language:en
Short-container-title:Indian J Gynecol Oncolog

Author:

Dakshinamurthy Soumya,Racherla Rishi Gowtham,Belagal Praveen,Bharathi T.,Sai Gopal D. V. R.

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s40944-022-00702-4.pdf

Reference48 articles.

1. Toh ZQ, Kosasih J, Russell FM, Garland SM, Mulholland EK, Licciardi PV. Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus. Infect Drug Resist. 2019;12:1951–67. https://doi.org/10.2147/IDR.S178381.

2. Stelzle D, Tanaka LF, Lee KK, Khalil AI, Baussano I, Shah AS, Dalal S. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161–9. https://doi.org/10.1016/S2214-109X(20)30459-9.

3. Schiffman M, Doorbar J, Wentzensen N, De Sanjosé S, Fakhry C, Monk BJ, Franceschi S. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016;2(1):1–20. https://doi.org/10.1038/nrdp.2016.86.

4. De Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17–27. https://doi.org/10.1016/j.virol.2004.03.033.

5. Berti FCB, Pereira APL, Cebinelli GCM, Trugilo KP, de Oliveira KB. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma. Cytokine Growth Factor Rev. 2017;34:1–13. https://doi.org/10.1016/j.cytogfr.2017.03.002.